"{'CDC25B': ['bipolar disorder'], 'KIF16B': ['asthma', 'type 1 diabetes'], 'FAM209B': ['obesity-related traits'], 'C20orf27': ['survival in colon cancer'], 'BPIFA2': ['smooth-surface caries'], 'TCFL5': ['obesity-related traits'], 'RNF24': ['response to antidepressants in depression', 'schizophrenia', 'idiopathic osteonecrosis of the femoral head', 'obesity-related traits', 'nevirapine-induced hypersensitivity in hiv (drug-induced liver injury)', 'height'], 'COMMD7': ['type 2 diabetes'], 'ANKRD60': ['height'], 'PSMF1': ['coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes', 'breast cancer', 'coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes', 'breast cancer'], 'MYBL2': ['autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)'], 'SIRPA': ['response to citalopram or escitalopram and depression', 'pulmonary function decline'], 'PLCB1': ['response to irinotecan in non-small-cell lung cancer', 'estradiol plasma levels (breast cancer)', 'response to paliperidone in schizophrenia (multivariate)', 'diastolic blood pressure', 'white blood cell count', 'response to irinotecan in non-small-cell lung cancer', 'estradiol plasma levels (breast cancer)', 'obesity-related traits', 'chronic kidney disease'], 'ISM1': ['survival in colon cancer'], 'ZFP64': ['facial morphology (factor 23)'], 'DEFB126': ['non-alcoholic fatty liver disease histology (other)'], 'DEFB127': ['body mass index'], 'MCM8': ['response to tocilizumab in rheumatoid arthritis', 'breast cancer', 'schizophrenia', 'intelligence (multi-trait analysis)', 'breast cancer'], 'PDYN': ['bipolar disorder and schizophrenia', 'bipolar disorder (body mass index interaction)', 'bipolar disorder and schizophrenia', 'verbal declarative memory', 'obesity-related traits', 'bipolar disorder (body mass index interaction)'], 'EYA2': ['type 2 diabetes', 'facial morphology (factor 19)', 'brain volume in infants (intracranial brain volume)', 'waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'waist-to-hip ratio adjusted for body mass index'], 'GDF5': ['waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'hip circumference adjusted for bmi', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for body mass index', 'height'], 'EFCAB8': ['type 1 diabetes nephropathy', 'attention deficit hyperactivity disorder (combined symptoms)'], 'ANGPT4': ['estradiol plasma levels (breast cancer)', 'estradiol plasma levels (breast cancer)'], 'MAPRE1': ['attention deficit hyperactivity disorder (combined symptoms)', 'attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)'], 'SIGLEC1': ['height'], 'ITPA': ['chronic obstructive pulmonary disease'], 'STK4': ['schizophrenia'], 'LZTS3': ['oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder', 'subcortical brain region volumes'], 'UQCC1': ['blood protein levels', 'waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for body mass index', 'height'], 'ZNF335': ['intelligence (multi-trait analysis)', 'coronary artery disease'], 'BCAS1': ['breast cancer', 'bipolar disorder and schizophrenia', 'bipolar disorder and schizophrenia', 'resting heart rate', 'breast cancer'], 'TCEA2': ['diastolic blood pressure'], 'CNBD2': ['hip circumference adjusted for bmi'], 'PROCR': ['blood protein levels', 'coronary artery disease', 'height'], 'SLC13A3': ['brain volume in infants (white matter)', 'chronic kidney disease'], 'PXMP4': ['height'], 'SNAP25': ['diisocyanate-induced asthma'], 'KCNS1': ['bipolar disorder'], 'CSE1L': ['non-response to citalopram or escitalopram and depression', 'intelligence', 'intelligence (multi-trait analysis)', 'subjective well-being'], 'RTEL1': ['allergic disease (asthma, hay fever or eczema)'], 'ADNP': ['prostate cancer'], 'SCRT2': ['colorectal cancer', 'lung function (fvc)', 'waist-to-hip ratio adjusted for body mass index', 'waist circumference adjusted for body mass index', 'waist circumference adjusted for bmi in active individuals', 'waist circumference adjusted for bmi (joint analysis main effects and physical activity interaction)', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'waist circumference adjusted for bmi in active individuals', 'waist circumference adjusted for bmi (joint analysis main effects and physical activity interaction)', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'body mass index', 'waist-to-hip ratio adjusted for body mass index', 'waist circumference adjusted for body mass index', 'height', 'sitting height ratio'], 'AHCY': ['liver fibrosis severity in hiv/hepatitis c co-infection'], 'NPBWR2': ['body mass index'], 'POFUT1': ['chronic obstructive pulmonary disease'], 'EPB41L1': ['height'], 'PTPRT': ['diisocyanate-induced asthma', 'response to paliperidone in schizophrenia (negative marder score)', 'facial morphology (factor 20)'], 'RAD21L1': ['brain structure', 'vascular brain injury', 'body mass index (recreational physical activity interaction)'], 'SIRPB1': ['yu-zhi constitution type in type 2 diabetes', 'brain connectivity', 'body mass index'], 'BPI': ['bipolar disorder and schizophrenia', 'bipolar disorder and schizophrenia'], 'SLC24A3': ['white blood cell count (basophil)', 'pulmonary function decline', 'age at smoking initiation in chronic obstructive pulmonary disease', 'liver enzyme levels (alanine transaminase)'], 'PLCG1': ['coronary artery disease', 'height'], 'CDS2': ['allergic disease (asthma, hay fever or eczema)', 'asparaginase hypersensitivity in acute lymphoblastic leukemia', 'white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)', 'sitting height ratio'], 'RRBP1': ['coronary artery disease'], 'PHACTR3': ['response to tocilizumab in rheumatoid arthritis', 'breast cancer', 'schizophrenia', 'intelligence (multi-trait analysis)', 'breast cancer'], 'CHD6': ['verbal declarative memory'], 'ESF1': ['intelligence (childhood)'], 'SIRPD': ['coronary artery aneurysm in kawasaki disease', 'obesity (extreme)'], 'NFATC2': ['allergic disease (asthma, hay fever or eczema)', 'asparaginase hypersensitivity in acute lymphoblastic leukemia', 'white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)', 'sitting height ratio'], 'MAVS': ['schizophrenia', 'circulating leptin levels adjusted for bmi', 'modified stumvoll insulin sensitivity index (bmi interaction)', 'liver fibrosis in pediatric non-alcoholic fatty acid liver disease'], 'GGT7': ['coronary artery disease'], 'FERMT1': ['survival in colon cancer'], 'CHGB': ['attention function in attention deficit hyperactive disorder', 'blood pressure', 'diastolic blood pressure', 'systolic blood pressure', 'coronary artery disease'], 'DEFB129': ['obesity-related traits'], 'RALY': ['breast cancer', 'cancer', 'cancer (pleiotropy)', 'facial pigmentation', 'breast cancer'], 'ACTR5': ['liver fibrosis in pediatric non-alcoholic fatty acid liver disease'], 'DEFB132': ['colorectal or endometrial cancer', 'red blood cell count', 'obesity-related traits'], 'MRGBP': ['subjective well-being'], 'CDK5RAP1': ['hair color'], 'RBBP8NL': ['coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes', 'coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes'], 'RBL1': ['height'], 'KIAA1755': ['heart rate', 'resting heart rate', 'heart rate variability traits (sdnn)', 'heart rate variability traits (rmssd)'], 'TM9SF4': ['chronic obstructive pulmonary disease'], 'ATRN': ['diisocyanate-induced asthma', 'breast cancer', 'response to paliperidone in schizophrenia (panss score)', 'response to paliperidone in schizophrenia (multivariate)', 'attention deficit hyperactivity disorder', 'congenital left-sided heart lesions', 'blood protein levels', 'coronary artery disease', 'breast cancer', 'waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'obesity-related traits', 'hip circumference adjusted for bmi', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for body mass index', 'height'], 'CHRNA4': ['facial morphology (factor 17, height of vermillion upper lip)', 'facial morphology (factor 17, height of vermillion upper lip)'], 'C20orf196': ['change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer', 'breast cancer', 'facial morphology (factor 1, breadth of lateral portion of upper face)', 'facial morphology (factor 1, breadth of lateral portion of upper face)', 'verbal declarative memory', 'systolic blood pressure', 'pulmonary function decline', 'change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer', 'breast cancer', 'obesity-related traits', 'height'], 'FKBP1A': ['intelligence (childhood)'], 'PTPN1': ['hair morphology'], 'NSFL1C': ['intelligence (multi-trait analysis)'], 'STK35': ['facial morphology (factor 7, width of cartilaginous portion of nose)', 'body mass index', 'height'], 'FAM110A': ['response to paliperidone in schizophrenia (multivariate)', 'obesity-related traits'], 'DDX27': ['intelligence (multi-trait analysis)'], 'BCL2L1': ['oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder', 'subcortical brain region volumes'], 'ZNF217': ['allergic disease (asthma, hay fever or eczema)', 'red blood cell count'], 'PTGIS': ['schizophrenia'], 'TOX2': ['red blood cell count'], 'CDH4': ['coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'bipolar disorder (body mass index interaction)', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'volumetric brain mri', 'coronary artery calcified atherosclerotic plaque (130 hu threshold) in type 2 diabetes', 'obesity-related traits', 'bipolar disorder (body mass index interaction)'], 'GNAS': ['event-related brain oscillations', 'waist circumference adjusted for body mass index', 'waist circumference adjusted for body mass index'], 'HNF4A': ['type 2 diabetes'], 'ARHGAP40': ['schizophrenia'], 'PMEPA1': ['verbal declarative memory'], 'ARFGEF2': ['anger'], 'MYT1': ['colorectal cancer'], 'LAMA5': ['colorectal cancer'], 'NRSN2': ['diisocyanate-induced asthma', 'breast cancer', 'response to paliperidone in schizophrenia (panss score)', 'response to paliperidone in schizophrenia (multivariate)', 'attention deficit hyperactivity disorder', 'congenital left-sided heart lesions', 'blood protein levels', 'coronary artery disease', 'breast cancer', 'waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'hip circumference adjusted for bmi', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for body mass index', 'height'], 'ADRA1D': ['diisocyanate-induced asthma', 'facial morphology (factor 20)'], 'SMOX': ['bone mineral accretion in asthma (oral corticosteroid dose interaction)', 'verbal declarative memory', 'coronary artery disease', 'height'], 'CST3': ['blood protein levels', 'chronic kidney disease'], 'NAPB': ['facial morphology (factor 15, philtrum width)'], 'TMEM230': ['prostate cancer', 'breast cancer', 'bipolar disorder', 'longitudinal change in brain amyloid plaque burden', 'breast cancer'], 'SULF2': ['attention deficit hyperactivity disorder (time to onset)'], 'PRNP': ['waist-to-hip ratio adjusted for body mass index', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'waist-to-hip ratio adjusted for bmi in active individuals', 'waist-to-hip ratio adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist-to-hip ratio adjusted for bmi (joint analysis for main effect and physical activity interaction)', 'waist-to-hip ratio adjusted for bmi (adjusted for smoking behaviour)', 'waist-to-hip ratio adjusted for body mass index'], 'PHF20': ['breast cancer', 'response to paliperidone in schizophrenia (panss score)', 'response to paliperidone in schizophrenia (multivariate)', 'breast cancer', 'height'], 'PPP1R16B': ['schizophrenia', 'alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis'], 'CTNNBL1': ['visceral adipose tissue adjusted for bmi'], 'SLC23A2': ['narcolepsy with cataplexy', 'colorectal cancer', 'alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)', 'non-response to citalopram or escitalopram and depression', 'depression', 'anger', 'schizophrenia', 'intelligence', 'intelligence (multi-trait analysis)', 'subjective well-being', 'diastolic blood pressure', 'coronary artery disease', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'obesity-related traits', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'height'], 'NCOA3': ['response to treatment for acute lymphoblastic leukemia'], 'DEFB128': ['c-reactive protein (red blood cell fatty acid level interaction)'], 'MMP24': ['attention deficit hyperactivity disorder'], 'SRXN1': ['hip circumference adjusted for bmi', 'height'], 'RBCK1': ['bone mineral accretion in asthma (oral corticosteroid dose interaction)', 'diisocyanate-induced asthma', 'non-response to bupropion and depression', 'response to paliperidone in schizophrenia (negative marder score)', 'facial morphology (factor 20)', 'verbal declarative memory', 'resting heart rate', 'coronary artery disease', 'height'], 'SOX12': ['type 1 diabetes nephropathy', 'type 2 diabetes', 'attention deficit hyperactivity disorder (combined symptoms)', 'attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)', 'subjective well-being', 'white blood cell count (basophil)'], 'BMP2': ['obesity-related traits'], 'UBOX5': ['red blood cell density in sickle cell anemia'], 'DTD1': ['obesity-related traits'], 'C20orf96': ['response to tocilizumab in rheumatoid arthritis'], 'TMC2': ['colorectal or endometrial cancer', 'red blood cell count', 'obesity-related traits'], 'MYH7B': ['congenital left-sided heart lesions'], 'CEP250': ['height'], 'SIRPG': ['type 1 diabetes'], 'PANK2': ['alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis'], 'KIZ': ['height'], 'ZSWIM3': ['waist circumference adjusted for bmi (smoking interaction)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi (smoking interaction)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)'], 'RAB22A': ['change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer', 'change in lvef in response to paclitaxel and trastuzumab in her2+ breast cancer'], 'GPCPD1': ['body mass index'], 'TRIB3': ['asthma', 'triglyceride change in response to fenofibrate in statin-treated type 2 diabetes', 'survival in colon cancer', 'bipolar disorder and schizophrenia', 'schizophrenia', 'autism spectrum disorder or schizophrenia', 'bipolar disorder', 'bipolar disorder and schizophrenia', 'heart rate', 'resting heart rate', 'heart rate variability traits (sdnn)', 'heart rate variability traits (rmssd)', 'visceral adipose tissue adjusted for bmi', 'circulating leptin levels adjusted for bmi', 'modified stumvoll insulin sensitivity index (bmi interaction)', 'alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis', 'liver fibrosis in pediatric non-alcoholic fatty acid liver disease', 'height'], 'SDCBP2': ['survival in colon cancer', 'personality traits in bipolar disorder', 'body mass index (alcohol intake interaction)'], 'ZBTB46': ['coronary artery disease', 'obesity-related traits'], 'SNPH': ['brain structure', 'blood metabolite levels', 'blood metabolite ratios', 'body mass index (recreational physical activity interaction)'], 'SLX4IP': ['fasting blood glucose adjusted for bmi', 'body mass index (change over time) in chronic obstructive pulmonary disease', 'fasting blood glucose adjusted for bmi', 'body mass index (change over time) in chronic obstructive pulmonary disease'], 'KCNB1': ['alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)', 'schizophrenia', 'intelligence (multi-trait analysis)', 'obesity-related traits'], 'NCOA6': ['diisocyanate-induced asthma', 'coronary artery disease', 'hip circumference adjusted for bmi'], 'ZNF133': ['body mass index'], 'ZNF343': ['diisocyanate-induced asthma', 'conotruncal heart defects (maternal effects)', 'blood protein levels', 'glomerular filtration rate in chronic kidney disease'], 'AP5S1': ['heart rate', 'resting heart rate', 'heart rate variability traits (sdnn)', 'heart rate variability traits (rmssd)'], 'BCAS4': ['breast cancer', 'breast cancer'], 'E2F1': ['asthma'], 'PREX1': ['narcolepsy with cataplexy', 'colorectal cancer', 'intelligence (multi-trait analysis)', 'diastolic blood pressure'], 'CSNK2A1': ['body mass index in non-asthmatics', 'allergic disease (asthma, hay fever or eczema)', 'osteoarthritis (hip)', 'type 2 diabetes (age of onset)', 'narcolepsy with cataplexy', 'prostate cancer', 'colorectal cancer (oestrogen-progestogen hormone therapy interaction)', 'colorectal cancer', 'breast cancer', 'response to treatment for acute lymphoblastic leukemia', 'asparaginase hypersensitivity in acute lymphoblastic leukemia', 'alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)', 'non-response to citalopram or escitalopram and depression', 'depression', 'anger', 'bipolar disorder and schizophrenia', 'schizophrenia', 'white matter microstructure in first episode schizophrenia (right anterior cingulate cortex)', 'bipolar disorder', 'bipolar disorder (body mass index interaction)', 'bipolar disorder and schizophrenia', 'bipolar disorder or attention deficit hyperactivity disorder', 'bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder', 'attention deficit hyperactivity disorder (time to onset)', 'attention deficit hyperactivity disorder', 'attention deficit hyperactivity disorder (combined symptoms)', 'attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)', 'bipolar disorder or attention deficit hyperactivity disorder', 'bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder', 'facial morphology (factor 23)', 'longitudinal change in brain amyloid plaque burden', 'intelligence', 'intelligence (multi-trait analysis)', 'subjective well-being', 'hair morphology', 'resting heart rate', 'diastolic blood pressure', 'red blood cell count', 'coronary artery aneurysm in kawasaki disease', 'coronary artery disease', 'breast cancer', 'waist-hip ratio', 'waist circumference', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'obesity', 'obesity-related traits', 'modified stumvoll insulin sensitivity index (bmi interaction)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'waist circumference adjusted for bmi in non-smokers', 'bmi (adjusted for smoking behaviour)', 'waist circumference adjusted for bmi (adjusted for smoking behaviour)', 'bmi in non-smokers', 'body mass index in non-asthmatics', 'bipolar disorder (body mass index interaction)', 'body mass index', 'body mass index (joint analysis main effects and smoking interaction)', 'height', 'sitting height ratio'], 'ZNF341': ['height'], 'TCF15': ['survival in colon cancer', 'non-alcoholic fatty liver disease histology (other)'], 'STAU1': ['intelligence (multi-trait analysis)', 'height'], 'CST1': ['blood protein levels'], 'BMP7': ['oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder', 'facial morphology (factor 5, width of mouth relative to central midface)', 'facial morphology (factor 5, width of mouth relative to central midface)'], 'SPTLC3': ['personality traits in bipolar disorder', 'body mass index (alcohol intake interaction)'], 'C20orf203': ['subjective well-being', 'white blood cell count (basophil)'], 'SCAND1': ['hip circumference adjusted for bmi'], 'SIRPB2': ['intelligence (multi-trait analysis)'], 'CD40': ['rheumatoid arthritis'], 'C20orf194': ['asthma', 'type 1 diabetes nephropathy', 'type 2 diabetes', 'breast cancer', 'cancer', 'cancer (pleiotropy)', 'attention deficit hyperactivity disorder (combined symptoms)', 'attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)', 'loneliness', 'smooth-surface caries', 'subjective well-being', 'hair color', 'white blood cell count (basophil)', 'red blood cell count', 'breast cancer', 'hip circumference adjusted for bmi', 'height'], 'PTK6': ['hair shape'], 'MACROD2': ['facial morphology (factor 10, width of nasal floor)', 'intelligence (multi-trait analysis)', 'coronary artery aneurysm in kawasaki disease', 'obesity (extreme)', 'obesity-related traits', 'body mass index', 'non-alcoholic fatty liver disease histology (other)'], 'NFS1': ['response to paliperidone in schizophrenia (panss score)', 'response to paliperidone in schizophrenia (multivariate)'], 'MMP24OS': ['attention deficit hyperactivity disorder'], 'TGM3': ['alanine aminotransferase (alt) levels after remission induction therapy in actute lymphoblastic leukemia (all)', 'facial morphology (factor 15, philtrum width)', 'obesity-related traits', 'liver enzyme levels (alanine transaminase)'], 'ABHD12': ['liver enzyme levels (alkaline phosphatase)'], 'CABLES2': ['coronary artery calcified atherosclerotic plaque score in type 2 diabetes', 'colorectal cancer', 'coronary artery calcified atherosclerotic plaque score in type 2 diabetes'], 'PCSK2': ['obesity-related traits'], 'PRPF6': ['colorectal cancer'], 'ZNF831': ['attention function in attention deficit hyperactive disorder', 'blood pressure', 'diastolic blood pressure', 'systolic blood pressure', 'coronary artery disease'], 'NOL4L': ['red blood cell count', 'chronic obstructive pulmonary disease'], 'TAF4': ['smooth-surface caries', 'body mass index'], 'ZHX3': ['non-response to bupropion and depression', 'resting heart rate', 'coronary artery disease', 'height'], 'DNMT3B': ['attention deficit hyperactivity disorder (combined symptoms)'], 'PAK5': ['obesity-related traits'], 'ZGPAT': ['prostate cancer', 'lung function (fev1)'], 'TBC1D20': ['asthma', 'rheumatoid arthritis', 'type 2 diabetes', 'pancreatic cancer', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'schizophrenia', 'bipolar disorder', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)', 'facial morphology (factor 13, vertical position of alar curvature relative to upper lip)', 'facial morphology (factor 21, depth of nasal alae)', 'brain structure', 'intelligence (multi-trait analysis)', 'blood protein levels', 'red blood cell count', 'coronary artery disease', 'current cigarettes per day in chronic obstructive pulmonary disease', 'waist circumference adjusted for bmi (smoking interaction)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)', 'obesity-related traits', 'waist circumference adjusted for bmi (smoking interaction)', 'waist circumference adjusted for bmi (joint analysis main effects and smoking interaction)'], 'PFDN4': ['obesity-related traits'], 'TSHZ2': ['bipolar disorder (body mass index interaction)', 'coronary artery aneurysm in kawasaki disease', 'bipolar disorder (body mass index interaction)'], 'CFAP61': ['exploratory eye movement dysfunction in schizophrenia (total eye scanning length)'], 'CRLS1': ['type 1 diabetes nephropathy', 'chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes', 'chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes'], 'TGM6': ['erectile dysfunction and prostate cancer treatment', 'body mass index (change over time) in cancer or chronic obstructive pulmonary disease', 'blood protein levels', 'body mass index (change over time) in cancer or chronic obstructive pulmonary disease', 'body mass index (change over time) in cancer or chronic obstructive pulmonary disease']}"